Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol Company's first metered-dose inhalation (MDI) product and establishes a new growth vector for the Affordable Medicines segment GlobeNewswire October 29, 2025 BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and […]

Sherman Portfolios Releases the Sherman Launch System (SLS), Delivering Real-Time Market Signals and Research for Financial Advisors GlobeNewswire October 29, 2025 COEUR D'ALENE, Idaho, Oct. 29, 2025 (GLOBE NEWSWIRE) — Sherman Portfolios, LLC (SPL), an SEC-registered investment adviser, today announced the release of the Sherman Launch System (SLS) — a subscription software platform that delivers

Shenandoah Telecommunications Company Reports Third Quarter 2025 Results GlobeNewswire October 29, 2025 EDINBURG, Va., Oct. 29, 2025 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced third quarter 2025 financial and operating results. Third Quarter 2025 Highlights Glo Fiber Expansion Markets revenue grew 41.1% compared to the third quarter of 2024

(NASDAQ:HWBK), JEFFERSON CITY, Mo., Oct. 29, 2025 (GLOBE NEWSWIRE) — Hawthorn Bancshares, Inc. (NASDAQ: HWBK) announced today that its Board of Directors approved a quarterly cash dividend of $0.20 per common share, payable January 1, 2026 to shareholders of record at the close of business on December 15, 2025. About Hawthorn Bancshares, Inc. Hawthorn Bancshares,

Hawthorn Bancshares Announces Cash Dividend GlobeNewswire October 29, 2025 JEFFERSON CITY, Mo., Oct. 29, 2025 (GLOBE NEWSWIRE) — Hawthorn Bancshares, Inc. (NASDAQ: HWBK) announced today that its Board of Directors approved a quarterly cash dividend of $0.20 per common share, payable January 1, 2026 to shareholders of record at the close of business on December

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team Renowned pain management and medical technology leader to accelerate Glucotrack's strategy for integrated glucose monitoring applications, building on Company's 2024 expansion into epidural monitoring GlobeNewswire October 29, 2025 RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc.(“Glucotrack”, or

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 GlobeNewswire October 29, 2025 VANCOUVER, Wash. and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial

(NYSE:VFC), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In V.F. Corporation (VFC) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in VFC between October 30, 2023, to May 20, 2025 and would like to discuss your legal rights, call Bragar Eagel &

VFC CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds VF Corporation Investors to Contact the Firm Before November 11th GlobeNewswire October 29, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In V.F. Corporation (VFC) To Contact Him Directly To Discuss Their Options If you purchased or acquired

A-Mark Precious Metals Announces Quarterly Cash Dividend GlobeNewswire October 29, 2025 EL SEGUNDO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, maintaining the company's current